OVCA

1 clinical trials · Condition

Record	Firm	Date
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors (NCT02573259)	Pfizer	2016-02-10

Every clearance here is in the API, with alerts when new ones post.